GCM
EGRX

Graham Capital Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Graham Capital Management’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,373
Closed -$64.7K – 1336
2023
Q4 		$64.7K Buy
+12,373
New +$64.7K ﹤0.01% 907